Front Page Congress Site WSAVA Author Index Search Go to First Presentation Go to Previous Presentation Go to Next Presentation Go to Last Presentation World Congress 2001 CVMA WSAVA
 
Back to Previous Page Print This Page Save This Page Bookmark This Page Go to the Top of the Page

SURVIVAL EVALUATION OF SYMPTOMATIC PARVOVIRUS INFECTED DOGS TREATED WITH A RECOMBINANT FELINE OMEGA INTERFERON

Mähl P, Maynard L, De Mari K, and Lebreux B

A study was designed to evaluate the efficacy of a recombinant feline omega interferon (rFeIFNw) in the treatment of canine parvovirus disease. In a multicentric, controlled, randomised and double blind clinical field trial, 177 dogs were included with a clinically diagnosed parvovirosis confirmed by ELISA and haemagglutination test on faeces. Eighty five dogs were given 2.5 million units (MU) interferon per kg body weight intravenously once a day for 3 days and 92 dogs received a placebo. Symptomatic treatment including rehydration, antibiotics, spasmolytic and antiemetic drugs was implemented for both groups. Dogs were clinically observed 6 times for 9 days and death date was recorded if appropriate. Efficacy was assessed through the survival probabilities which were calculated by the KAPLAN-MEIER method and compared by the LOGRANK test. 8 (9.4%) dogs died during the observation period in rFeIFNw group and 18 (19.6%) in the placebo group. Comparison of the survival curves showed a statistically significant difference between groups (p = 0.0300). Safety of the product based on clinical examination was excellent. After 3 IV injections of 2.5 MU/kg rFeIFNw , the survival probability was significantly higher in treated dogs than in placebo, with the mortality rate being 2.3 times lower in the treated group.


Back to Previous Page Print This Page Save This Page Bookmark This Page Go to the Top of the Page

Alternative Medicine
Anesthesia
Animal Welfare
Behaviour
Cardiology
Clinical Pathology
Dental Congress 1:1
Dental Congress 1:2
Dental Congress 1:3
Dental Congress 2:1
Dental Congress 2:2
Dental Congress 2:3
Dermatology
Emergency & Critical Care
Feline Endocrine & Infectious Dz
Feline Gastroenterology
Feline Urology/Nephrology
Gastroenterology
Imaging
Infectious & Zoonotic Diseases
Management
Medicine
Neurology
Nutrition
Oncology
Ophthalmology
Pharmacology
Respiratory Medicine
Surgery & Sports Medicine
Surgery
Oral Presentations
Poster Presentations
 
Bartonella Transmission, Cats
 
Romifidine/Butorphanol Inj., Cats
 
Small Animal Practice, Iran
 
Effect Of Mammary Tumors On Ovary
 
Brucellosis Test Comparison, Dogs
 
Antioxidants Aid Immune System
 
Parathormone Assay In Dogs
 
Moxidectin Treatment Of Scabies
 
Canine Babesiosis, Taiwan
 
ECG/BP After Propofol Administration
 
Bilateral TPO
 
Urethrostomy: Perineal vs Abdominal
 
Periodontal Dis.: CRF vs Normal Dogs
 
Wound Healing Using Bovine Saliva
 
Unhappiness With Assistance Dogs
 
Rabies Diagnosis In Live Dogs
 
Heartworm Diag.: Antigens/Antibodies
 
Penrose Drains For Peritonitis
 
Age Changes In Joint Cartilage
 
You are hereFeline Interferon For Parvo Dogs
 
Electrocardiographic, First 30 Days
 
Ehrlichiosis Prevalence, Taiwan
 
Moxidectin Effects On Demodicosis
 
ECG Results, Chronic Valve Disease
 
Chlorhexidine Gel, Plaque Reduction
 
Treated Rawhide, Plaque Reduction
 
Gingivitis, Dentisept's Effects
 
Determinants Of Owner Compliance
 
Indirect BP Measurement Methods
 
Carnitine's Effects On Obese Cats
 
Angiographic Sudies, Tibial Bone
 
Hip Dysplasia, Darthroplasty, Dogs
 
Cabergoline Abortion In Cats